Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Zeitlinger

Showing results (241-250 of 352) with videos related to

Pageof 36
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 20, 2026
When and How to Use Subcutaneous AntibioticsStefano Di Bella, Nicholas Geremia, Federico Pea, et al.
Clinical Pharmacokinetics|October 18, 2025
Randomized, Double-Blind, Phase I Pharmacokinetic Study of Subcutaneous Recombinant Human Superoxide Dismutase (rhSOD) in Healthy VolunteersValentin Al Jalali, Martin Bauer, Anselm Jorda, et al.
Antibiotics (Basel, Switzerland)|December 29, 2020
Meropenem Plasma and Interstitial Soft Tissue Concentrations in Obese and Nonobese Patients-A Controlled Clinical TrialPhilipp Simon, David Petroff, David Busse, et al.
Neurocritical Care|November 20, 2015
Cerebral and Peripheral Metabolism to Predict Successful Reperfusion After Cardiac Arrest in Rats: A Microdialysis StudyA Hosmann, A Schober, A Gruber, et al.
Journal of Clinical Medicine|April 15, 2020
Linezolid Concentrations in Plasma and Subcutaneous Tissue are Reduced in Obese Patients, Resulting in a Higher Risk of Underdosing in Critically Ill Patients: A Controlled Clinical Pharmacokinetic StudyPhilipp Simon, David Busse, David Petroff, et al.
British Journal of Anaesthesia|February 2, 2025
Evaluation of the need for dosing adaptations in obese patients for surgical antibiotic prophylaxis: a model-based analysis of cefazolin pharmacokineticsDavide Bindellini, Philipp Simon, David Busse, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 26, 2024
Prevalence and clinical implications of bloodstream infections in intensive care patients with or without burn injury: a retrospective cohort studyFelix Bergmann, Anselm Jorda, Julia Sollner, et al.
European Journal of Clinical Pharmacology|May 17, 2019
The European Association for Clinical Pharmacology and Therapeutics-25 years' young and going strongJamie J Coleman, Caroline Samer, Markus Zeitlinger, et al.
Critical Care (London, England)|July 11, 2024
Fluid management for sepsis-induced hypotension in patients with advanced chronic kidney disease: a secondary analysis of the CLOVERS trialAnselm Jorda, Ivor S Douglas, Thomas Staudinger, et al.
The Journal of Antimicrobial Chemotherapy|July 20, 2024
Pharmacokinetic/pharmacodynamic model-based optimization of temocillin dosing strategies for the treatment of systemic infectionsWisse van Os, Alina Nussbaumer-Pröll, Anh Duc Pham, et al.
Pageof 36

Showing results (241-250 of 352) with videos related to

Sort By:
Pageof 36
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 20, 2026
When and How to Use Subcutaneous AntibioticsStefano Di Bella, Nicholas Geremia, Federico Pea, et al.
Clinical Pharmacokinetics|October 18, 2025
Randomized, Double-Blind, Phase I Pharmacokinetic Study of Subcutaneous Recombinant Human Superoxide Dismutase (rhSOD) in Healthy VolunteersValentin Al Jalali, Martin Bauer, Anselm Jorda, et al.
Antibiotics (Basel, Switzerland)|December 29, 2020
Meropenem Plasma and Interstitial Soft Tissue Concentrations in Obese and Nonobese Patients-A Controlled Clinical TrialPhilipp Simon, David Petroff, David Busse, et al.
Neurocritical Care|November 20, 2015
Cerebral and Peripheral Metabolism to Predict Successful Reperfusion After Cardiac Arrest in Rats: A Microdialysis StudyA Hosmann, A Schober, A Gruber, et al.
Journal of Clinical Medicine|April 15, 2020
Linezolid Concentrations in Plasma and Subcutaneous Tissue are Reduced in Obese Patients, Resulting in a Higher Risk of Underdosing in Critically Ill Patients: A Controlled Clinical Pharmacokinetic StudyPhilipp Simon, David Busse, David Petroff, et al.
British Journal of Anaesthesia|February 2, 2025
Evaluation of the need for dosing adaptations in obese patients for surgical antibiotic prophylaxis: a model-based analysis of cefazolin pharmacokineticsDavide Bindellini, Philipp Simon, David Busse, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 26, 2024
Prevalence and clinical implications of bloodstream infections in intensive care patients with or without burn injury: a retrospective cohort studyFelix Bergmann, Anselm Jorda, Julia Sollner, et al.
European Journal of Clinical Pharmacology|May 17, 2019
The European Association for Clinical Pharmacology and Therapeutics-25 years' young and going strongJamie J Coleman, Caroline Samer, Markus Zeitlinger, et al.
Critical Care (London, England)|July 11, 2024
Fluid management for sepsis-induced hypotension in patients with advanced chronic kidney disease: a secondary analysis of the CLOVERS trialAnselm Jorda, Ivor S Douglas, Thomas Staudinger, et al.
The Journal of Antimicrobial Chemotherapy|July 20, 2024
Pharmacokinetic/pharmacodynamic model-based optimization of temocillin dosing strategies for the treatment of systemic infectionsWisse van Os, Alina Nussbaumer-Pröll, Anh Duc Pham, et al.
Pageof 36